Fujian Medical University Union Hospital
Clinical trials sponsored by Fujian Medical University Union Hospital, explained in plain language.
-
New stem cell combo could boost survival in blood cancer patients
Disease control Recruiting nowThis study is testing a new way to do stem cell transplants for people with acute myeloid leukemia (AML) or high-risk myelodysplastic syndromes (MDS). It combines stem cells from a half-matched donor (haploidentical) with cord blood, given at different times. The goal is to help …
Phase: NA • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
New vaccine aims to keep leukemia in remission
Disease control Recruiting nowThis study tests a personalized vaccine made from a patient's own leukemia cells to help prevent the cancer from coming back. It is for adults with acute myeloid leukemia who are in remission after chemotherapy. The vaccine is designed to train the immune system to recognize and …
Phase: PHASE1 • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Could a liver-protecting herb boost leukemia chemo? new trial aims to find out.
Disease control Recruiting nowThis study is for adults newly diagnosed with a type of acute myeloid leukemia (non-M3). It tests whether adding silibinin, a natural compound from milk thistle that protects the liver, to standard chemotherapy can improve remission rates and survival. About 100 participants will…
Phase: PHASE4 • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Could stem cell 'messages' regrow hair? new trial begins.
Disease control Recruiting nowThis study tests whether tiny particles from stem cells (exosomes) can safely help regrow hair in men with androgenic alopecia (male pattern baldness). The exosomes are delivered into the scalp using a microneedle device. The trial will enroll 18 men aged 18 to 60 with mild to mo…
Phase: NA • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New combo aims to beat bladder cancer without removing the bladder
Disease control Recruiting nowThis study tests whether a combination of two targeted drugs (zanidatamab and tislelizumab) plus chemotherapy can shrink HER2-positive muscle-invasive bladder cancer enough to avoid bladder removal. About 25 adults with stage T2-T4a bladder cancer will receive the treatment befor…
Phase: PHASE2 • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New Biomarker-Guided cocktail aims to wipe out esophageal cancer before surgery
Disease control Recruiting nowThis phase 2 trial is testing whether a personalized treatment plan based on a biomarker (CPS score) can improve outcomes for people with a certain type of esophageal cancer. Participants will receive a combination of the immunotherapy drug serplulimab, chemotherapy, and possibly…
Phase: PHASE2 • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated Jun 26, 2026 17:14 UTC
-
Smart wearables and blood markers could spot Parkinson's years before symptoms worsen
Diagnosis Recruiting nowThis study aims to find better ways to diagnose Parkinson's disease in its earliest stages. Researchers will use wearable devices to track movement and analyze blood samples for specific markers from nerve cells. By combining these digital and biological clues, they hope to creat…
Sponsor: Fujian Medical University Union Hospital • Aim: Diagnosis
Last updated Jul 02, 2026 05:00 UTC
-
Fewer needles, same accuracy? new prostate biopsy study aims to reduce harm
Diagnosis Recruiting nowThis study compares a personalized biopsy method that uses fewer needle cores to the standard approach for diagnosing prostate cancer. Researchers will enroll 330 men with suspected prostate cancer and randomly assign them to either the personalized or standard biopsy. The goal i…
Phase: NA • Sponsor: Fujian Medical University Union Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:05 UTC
-
Can a magnetic helmet slow Alzheimer's? new trial aims to find out
Symptom relief Recruiting nowThis study tests whether a non-invasive magnetic brain stimulation technique (rTMS) can improve thinking and memory in people with mild-to-moderate Alzheimer's disease. Researchers will also use brain scans to see if the treatment helps clear waste from the brain. The trial invol…
Phase: NA • Sponsor: Fujian Medical University Union Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Bone marrow secrets could predict chemo success in leukemia
Knowledge-focused Recruiting nowThis study is looking at substances in the bone marrow of adults with acute myeloid leukemia (AML) to see if they can predict how well chemotherapy will work. Researchers will measure certain factors in bone marrow samples from 405 newly diagnosed AML patients and compare them to…
Sponsor: Fujian Medical University Union Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Bone marrow fat hormone may reveal chemo resistance in leukemia
Knowledge-focused Recruiting nowThis study looks at whether a hormone called leptin, found in bone marrow, can predict how well chemotherapy works in adults with acute myeloid leukemia (AML). Researchers will measure leptin levels in bone marrow samples from 86 newly diagnosed patients before treatment and comp…
Sponsor: Fujian Medical University Union Hospital • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:33 UTC